GilbertMertens knows pharma inside out: he’s served the sector in Europe & USA for 30 years.
He was General Manager Business Development and Communication at Merck KGaA until 2004. He served at Merck KGaA from 1982 to 2004.
Before joining Merck KGaA, Gilbert Mertens successfully managed the Paris (France) office of an international communications agency. He holds a French Bachelor of Science degree in Sociology, Politics & Psychology, a Master of Science in Public Policy & Governance,and a Master’s degree in Business Administration & Management Sciences.
Mr. Mertens serves as an Adviser in matters of healthcare to international institutions and financial institutions. He serves as a Member of Advisory Board at Paris & London based DragonKnight Advisors SARL of Benelux based Vemediapharma, and as Member of Scientific Advisory Board at Switzerland based International Streamline Academy. He is the owner of Germany based Remed’X GmbH, a trend analysis in healthcare company, also known for its European and Northamerican Mergers & Acquisitions activities (in cooperation with DZ Bank, MM Warburg and other financial institutions and investment groups).
With the contribution of many worldwide recognized experts, scientists and global business leaders in all matters covering the broad sector of pharmaceuticals, biotech, & healthcare, Gilbert Mertens has expounded some of his vast learning in a dozen of books so far; among them: The Molecular Revolution (2008) – a sourcebook of data and analysis within oncology, immunology, degenerative diseases and other targeted therapy segments; and New Thinking: Outsmarting Cancer Cells (2013). A preview of future cancer therapies and medicines. He was among the very first to write about the misuse of antibiotics, about precision medicine and inspired many researchers by his "Mastering the Complexities of Women Healthcare"global call for targeted medicines. His positive views on the future of medicine made him a welcome speaker at conferences. His series of Healthcare Management reports, published by the Financial Times and by Reuters Business Insight have been received within the global medico- pharmaceutical business community as benchmark publications.
(Source: Financial Times, Reuters, Merck KGaA press release, Nicholas Hall & Co, Bloomberg http://www.bloomberg.com/research/stocks/private/person.asp?personId=8713638&privcapId=59703206 )
29 works Add another?
Most Editions
Most Editions
First Published
Most Recent
Top Rated
Reading Log
Random
Showing all works by author. Would you like to see only ebooks?
Subjects
Communication, placebo, Advertising, Alzheimer's disease, Auto-immune disease, Breast cancer, Communicatie, Complimentary therapies, Contraception, Dictionaries, FDA, Francophonie, Franglais, French, Functional Food, Germany, HRT, Healthcare, Heart disease, Homeopathy, Hormones, Infertility, Media, Menopaus, Menstrual irregularitiesPeople
& President of the American Society of Pharmacognosy, ARC, Adlercreuz Herman ( Professor, American Botanical Council, Argentina); Dickinson Annette (Scientific and Regulatory Affairs, Australia); Davis Marvin ( Department of Pharmacology, Boyce Thompson Institute for Plant Research, Cancer Prevention Research Program, Channel Four News, College of Natural Resources, Cornell University Medical College; Clinical Nutrition Research Coordinator at Memorial Sloan-Kettering Cancer Center and Rockefeller University, Council for Responsible Nutrition, Cristoph Gloekler, Dept. of Clinical Chemistry, Developmental Therapeutics Program, Dieter Hebal, Dip. Sci. & Techn. Dep., Dr Arthur Margolin, Dr Barry L Beyerstein, Dr Bryan Fernandes, Dr Daniel Eskinazi, Dr Jacques Boniver, Dr Johanne Colin, Dr Patrick Ober, Dr Ted KaptchukTime
2000-2020, 2005-2020, 21st century mediclnes, history & future of alternative healing/therapiesID Numbers
- OLID: OL1173486A
Links outside Open Library
No links yet. Add one?
August 19, 2021 | Edited by Edith Leclercq | Added new photo |
May 7, 2016 | Edited by Jim Harrilson | Completed the bio |
April 25, 2016 | Edited by Jim Harrilson | Completed the information on the author |
March 25, 2016 | Edited by Etienne de Courcelles | added information. |
April 1, 2008 | Created by an anonymous user | initial import |